New articles in the NEJM, Covid-19 & vaccine trials

While the world’s social media is inundated with populist commentary on the coronavirus, here is a tempered comment on what our appropriate response should be. https://www.nejm.org/doi/full/10.1056/NEJMp2003762?query=TOC #coronavirus #vaccines” Above article refers to Bill Gate’s position on Covid-19. In this he mentioned the importance of vaccines. A vaccine to interrupt the transmission of tuberculosis is also…

BTZ043 press release

PRESS RELEASE Tuberculosis: New drug substance BTZ-043 is being tested on patients for the first time A crucial step in the development of a promising new drug which has also proven to be effective against multidrug-resistant pathogens in preclinical tests The Tropical Institute at the Hospital of the Ludwig-Maximilians-Univer- sity (LMU) Munich is currently conducting…

GCP International course

Recently TASK Academy, a specific group of staff within the larger company focused on training and skills development, presented on “Implementing Good Clinical Practice at the (trial) site”. This during the kick-off meeting of the European-Latin American TB research collaboration network (EUSAT-RCS), held at the Radboud university medical centre, Nijmegen, the Kingdom of the Netherlands.…

Applications open for the PanACEA Postgraduate Studentships: Submission deadline 30 September

We are pleased to announce the opening of our Postgraduate programme, which will offer candidates a unique opportunity to support PanACEA objectives and obtain a research degree. The research programmes will be sponsored by expertise core and other affiliated resources. Candidates will be matched to appropriate projects based on their scientific interests, experience and acumen.…